This study aimed to determine the timing of ovulation in response to a new induced ovulation regime for the monovulatory brushtail possum (Trichosurus vulpecula). Ovarian stimulation was achieved by a single subcutaneous injection of 15 IU pregnant mare serum gonadotrophin (PMSG). This treatment res
Pharmacokinetics of antipyrine, warfarin and paracetamol in the brushtail possum
β Scribed by C. T. Eason; G. R. G. Wright; R. Gooneratne
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 61 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0260-437X
No coin nor oath required. For personal study only.
β¦ Synopsis
The plasma pharmacokinetics of antipyrine, warfarin and paracetamol have been studied in the Australian brushtail possum (Trichosurus vulpecula). The plasma elimination half-lives (t1/2) were 1.2 h for antipyrine, 11.9 h for warfarin and 5.2-12.9 h for paracetamol. Our data indicate that the clearance of these three xenobiotics in the possum is similar to that reported in eutherian mammals. There was no dose-dependent increase in paracetamol plasma t1/2 over the dose range 100-1000 mg kg(-1), indicating a lack of capacity saturation. This observation may in part explain the unusual resistance of the possum to the hepatotoxic effect of high doses of paracetamol.
π SIMILAR VOLUMES
We have identified differences in transport properties of intestinal epithelia in the marsupial brushtail possum, compared to eutherian mammals. To determine whether differences in its permeability to hydrophilic compounds also occur, the absorption of sodium fluorescein and luteinizing hormone rele
The transfer of animals from the wild into captivity is an important strategy for the conservation of species that are under threat of extinction. To determine the reproductive capability of animals following transfer from the wild, brushtail possums relocated from Brisbane, Adelaide, and Armidale i
The influence of vitamin C on the pharmacokinetics of antipyrine was investigated in eleven elderly men aged 65-74. Antipyrine (15 mg kgl) was administered intravenously on three separate occasions over a 7-week period: (a) before dietary vitamin C restriction, (b) after approximately 5 weeks of die